Augment the Team
Add capacity and specialized expertise.
Every engagement starts with a commercial problem. Here’s what our clients hire us to solve.
Clarify the positioning, messaging, and commercial story your buyers, investors, partners, and other stakeholders need to understand.
Bring us in alongside an established team, give us responsibility for the functions that need work, or have HTG operate most of marketing.
Help commercial teams understand the market, reach the right buyers, and turn technical differentiation into a stronger commercial position.
Make it easier for buyers, partners, investors, search engines, and AI-driven research tools to find and understand the company.
Use conferences and events to create meaningful commercial opportunities before, during, and after the event. End-to-end conference production, trade shows, VIP events, and symposia.
Develop the positioning, market story, investor materials, and commercial evidence needed to communicate the opportunity clearly.
We work in diagnostics, medtech, and biotech, and with the companies that serve them.
In PE-backed companies, marketing must support the commercial plan with the speed and accountability the company's growth objectives require.
HTG can work alongside the existing team, take responsibility for specific marketing functions, or operate most of marketing. We also support post-acquisition marketing integration, measurement and reporting, and the information management and boards need to understand what marketing is producing.
Add capacity and specialized expertise.
Take responsibility for the areas that need stronger execution.
Operate the function with company leadership setting commercial priorities and appropriate approvals.
We work as an embedded partner for companies with ongoing commercial and marketing needs. The engagement structure adapts to where you are. The depth doesn't.
A 12-month engagement at a fixed monthly rate. We operate as an embedded extension of your commercial and marketing function. We know your science, your market, your competitors, and your goals. We build on that knowledge month over month. The briefs get shorter. The strategy gets sharper. Momentum builds. Retainer clients see better outcomes across the board. We're transparent about this because it's the most useful thing we can tell you before you decide how to engage.
Some engagements have a clear beginning and end: a market entry strategy, a scientific conference, a product launch, a pitch deck, sales team training, a competitive intelligence report. We scope it, price it, and deliver it. Projects are also a natural first step for companies that want to see how we work before committing to a longer engagement.
Building your commercial story from the ground up?
Our Commercial Readiness Sprints are 30- to 60-day fixed-fee engagements designed for early-stage founders.
You're pre-commercial, pre-Series A, or somewhere in between. Your science is solid. Your commercial story isn't landing yet.
Our Commercial Readiness Sprints are 30- to 60-day engagements that get your positioning, messaging, and investor-facing assets where they need to be. All are fixed fee, senior-led, and include direct access to Elizabeth Chabe, HTG CEO and the bestselling author of The Giant's Ladder: The Science Professional's Blueprint for Marketing Success.
Investor-ready messaging, a core strategic asset, and a written brief with next steps.
Everything in Messaging Ready, plus a fully refined investor pitch deck and a curated VC targeting list with outreach strategy.
Everything in Pitch Ready, plus an expanded VC and partner targeting plan and a founder-ready channel and marketing plan.
All Sprints include a direct strategy session with Elizabeth Chabe, CEO of High Touch Group and bestselling author of The Giant's Ladder.


Elizabeth Chabe (MBA) is the founder and CEO of High Touch Group and the author of The Giant’s Ladder: The Science Professional’s Blueprint for Marketing Success. She has spent her career at the intersection of science and commercial strategy, working with diagnostics and medtech founders, advising VC firms, and consulting for national health agencies. Since 2018, she has served as a governor-appointed director of the Maine Venture Fund, where she advises portfolio companies and helps direct strategic investments.
Get the BookThe definitive guide for scientists and founders who need to think like marketers.
